Mar
07
Vagus nerve stimulation was approved by the Food and Drug Administration (FDA) in the summer of 2005 for the treatment of chronic, or recurrent, treatment-resistant depression (not as a first-line treatment). More specifically, it is indicated for those whose depression has not responded to the usual treatments. As with deep brain stimulation this is not a treatment that is for everyone. Vagus nerve stimulation also did not effectively treat
Read the rest of this entry
